Buckley Wealth Management, LLC Eli Lilly & CO Transaction History

Buckley Wealth Management, LLC

$319 Million
Q3 2024

A detailed history of Buckley Wealth Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Buckley Wealth Management, LLC holds 527 shares of LLY stock, worth $393,247. This represents 0.15% of its overall portfolio holdings.

Number of Shares

527

Previous 490 7.55%

Holding current value

$393,247

Previous $443,000 5.19%

% of portfolio

0.15%

Previous 0.14%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	BUY	$772.14 - $960.02 $28,569 - $35,520	37 Added 7.55%	527 $466,000
Q2 2024 Jul 23, 2024	SELL	$724.87 - $909.04 $2,174 - $2,727	-3 Reduced 0.61%	490 $443,000
Q1 2024 Apr 15, 2024	BUY	$592.2 - $792.28 $291,954 - $390,594	493 New	493 $383,000
Q1 2021 Apr 30, 2021	SELL	$164.32 - $212.72 $431,175 - $558,177	-2,624 Closed	0 $0
Q4 2020 Jan 20, 2021	BUY	$130.46 - $172.63 $652 - $863	5 Added 0.19%	2,624 $443,000
Q3 2020 Oct 19, 2020	SELL	$146.22 - $169.13 $102,061 - $118,052	-698 Reduced 21.04%	2,619 $388,000
Q1 2020 Apr 10, 2020	SELL	$119.05 - $147.35 $28,572 - $35,364	-240 Reduced 6.75%	3,317 $460,000
Q3 2019 Oct 11, 2019	SELL	$106.79 - $116.16 $11,212 - $12,196	-105 Reduced 2.87%	3,557 $398,000
Q1 2019 Apr 11, 2019	SELL	$111.31 - $131.02 $3,339 - $3,930	-30 Reduced 0.81%	3,662 $475,000
Q4 2018 Feb 01, 2019	SELL	$105.9 - $118.64 $36,006 - $40,337	-340 Reduced 8.43%	3,692 $427,000
Q2 2018 Jul 31, 2018	SELL	$75.7 - $86.88 $30,658 - $35,186	-405 Reduced 9.13%	4,032 $344,000
Q1 2018 May 08, 2018	SELL	$74.21 - $87.6 $40,444 - $47,742	-545 Reduced 10.94%	4,437 $343,000
Q4 2017 Feb 07, 2018	BUY	$81.94 - $87.89 $408,225 - $437,867	4,982	4,982 $421,000

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $709B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Buckley Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Buckley Wealth Management, LLC with notifications on news.

Account

Buckley Wealth Management, LLC Eli Lilly & CO Transaction History